LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 1,864 pages found matching %3Cscript%3Ealert%28%27What_Security?%27%29%3C/script%3E- Lawsuit Status Update: The Latest on Januvia Lawsuits
Jun-20-13 Januvia Lawsuits Quick Refresher: Januvia (Merck & Co., Inc.) is a drug prescribed to help treat adults with type-2 diabetes. On September 25, 2009 the FDA issued a revision to the warning label of the drug Januvia or Janumet, a combination drug comprised of Januvia and Metformin, regarding Januvia side effects , including Januvia pancreatic canc... - File a Risperdal Claim Sooner Than Later, Says Diabetes Victim
Apr-30-14 Pueblo, CO Cathy wasn’t aware of Risperdal diabetes until her daughter discovered the link. By that time it was too late; a Risperdal attorney investigated her claim but it was beyond the statute of limitations, even though Cathy will be on total disability for the rest of her life. Cathy (not her real name) started taking Risperdal in her lat... - Internet Payday Lender Accused of Charging Minnesotans Predatory Interest Rates
Apr-25-14 Ramsey County, MN An Internet payday lender that attempted to duck behind the protective shield of the Dormant Commerce Clause of the US Constitution, will have that cloak yanked away following a decision by the Court of Appeals. Internet payday lending has exploded in both popularity and prevalence in recent years, in spite of predatory interest ra... - Things Could Heat Up for Januvia and Cancer This Summer
May-31-13 Berkeley, CA While there may not be quite as many Januvia and cancer lawsuits as there are for a competing diabetes drug, the stakes are high for the manufacturer of sitagliptin (Januvia). According to The International Herald Tribune (5/29/13), Januvia and its close cousin Janumet enjoyed global sales of $5.7 billion between them in 2012. The con... - Debt Collector Harassment a Serious Problem
Mar-20-14 Washington, DC A recently released report suggests that concern about debt collector harassment is widespread, and that some illegal bill collector practices are taking their toll on consumers. In response to growing anger over debt collector practices, in July 2013, the Consumer Financial Protection Bureau began recording data regarding debt collectio... - FDA Plays Down Victoza Cancer Concern, but Plaintiffs Beg to Differ
Mar-19-14 Washington, DC The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) may have agreed that there isn’t a lot to talk about with regard to Victoza side effects . To wit, the two health regulators have parked any provocative concern over pancreatitis and precancerous changes to the pancreas with regard to Victoza and other... - Testosterone Side Effects Get a Rise Out of Consumer Advocate
Mar-18-14 Chicago, IL The dramatic rise in popularity of testosterone-boosting products has not only resulted in record sales for the manufacturers of such products as AndroGel, Androderm, Axirom and Bio-T-Gel (among others), the phenomenon of “Low-T” will soon be reverberating through the courts. Plaintiffs having brought many a testosterone lawsuit... - Both Sides Digging In for Pending Zimmer NexGen Lawsuit
May-24-13 Warsaw, IN The continuing controversy surrounding Zimmer Knee Replacement is destined for the courts, with the first bellwether NexGen lawsuit expected in 2014. And while Zimmer continues to hold that NexGen total knee replacement systems are reliable and some of the most widely used, the existence of a sizable product liability case serves to temper t... - Cigna Settles Denied Disabilities Claims
May-23-13 Bangor, ME Cigna has agreed to settle wrongly denied disability claims with a variety of states. The states alleged three Cigna-operated companies improperly handled insurance claims. Improperly denied insurance claims can lead to bad faith insurance lawsuits against insurance companies. Maine Insurance Superintended Eric Cioppa announced on May 22,... - Arkansas Seeks Review of Court Risperdal Reversal
Apr-12-14 Little Rock, AR Although Johnson & Johnson won a reversal of a $1.2 billion judgment in an Arkansas Risperdal lawsuit , Arkansas Attorney General Dustin McDaniel asked the state Supreme Court to reconsider its decision. The Arkansas Risperdal lawsuit alleged Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, minimized the risks of Ri... - Pre-Settlement Funding: Understand the Terms
May-21-13 Washington, DC While not exactly new, pre-settlement funding is beginning to weave its way into the public consciousness as a welcome resource for plaintiffs in the throes of litigation and in need of any settlement funding that may be forthcoming. The idea is to have immediate access to settlement or compensation funds through a third party while liti... - Specialists Agree: Yasmin Caused Blood Clot
Mar-13-14 Stafford, VA It doesn’t take long to develop a blood clot as a result of taking Yasmin birth control. Barbara, age 27, only took the Yasmin pill for nine months and says she is lucky to be alive. It started with a pain in her leg just six months after she started Yasmin, but it only lasted a few minutes so she thought it was just a cramp. But... - Off-the-Clock Work Alleged at Waste Management Inc.
May-5-13 Houston, TX On the surface, an unpaid wages lawsuit would suggest that work is performed without receiving compensation. But there is a grey area. Were an employee be required to don and then doff cumbersome uniforms or protective gear prior to starting work, one would assume the donning of protective gear required by the employer would be met with com... - Accutane Concerns Stretch Back Years
May-2-13 Santa Fe, NM Although Accutane has been off the market for a few years, some Accutane lawsuits may still be considered by patients who believe they suffered Accutane side effects. Concerns about Accutane side effects, which reportedly include depression, suicidal thoughts and inflammatory bowel disease, date back almost 20 years. The Canadian Broadc... - Zimmer NexGen Claimant Hopeful with Latest Zimmer Litigation
Mar-24-14 Chicago, IL Sherry, along with thousands of other Zimmer NexGen knee recipients, is paying close attention to the NexGen Knee implant multidistrict litigation. And Zimmer Knee Replacement lawsuits continue to be filed. Susan filed a Zimmer NexGen claim after she picked up copies of her medical records that showed both knees appeared to have the refe... - Federal Judge Gives Nod to $300 Million-Plus Force-Placed Insurance Settlement
Mar-23-14 Miami, FL A tentative $300 million Lender insurance settlement that was announced last September and given preliminary approval a month later has been granted final approval by a federal judge in Florida. The settlement not only provides some compensation for plaintiffs embroiled in the Force-Place insurance battleground, but legal experts agree the se... - Asbestos Drilling Mud Exposure a Concern Decades Later
Feb-21-14 Corvallis, OR One of the recurring themes with asbestos, whether dealing with asbestos drilling mud , asbestos in construction or asbestos in any of a number of other industries, is that asbestos exposure can come back to haunt a person many years later. And it does not matter if a person was exposed to asbestos through drilling mud or any other manner,... - Banks Accused of Aiding and Abetting Predatory Internet Payday Loans
Feb-18-14 Four Oaks, NC Victims of Internet payday loan proprietors and the predatory interest rates they charge have a friend in the US Justice Department. As various states have taken matters into their own hands and launched Internet payday loan lawsuits against Internet lenders, the feds have launched their own initative. Dubbed “Operation Choke Point,... - Police Officer Dropped His Cell Phone, Resulting in Back and Neck Injury
Feb-14-14 Sarasota, FL When a Sarasota police officer dropped his cell phone while driving and took his eyes off the road for a split second to retrieve it, that’s all it took for a 30-year-old woman to be left with back and neck injury after her car was rear-ended. When the injured woman filed a lawsuit, the city of Sarasota and the plaintiff are reported... - FDA to Wait For Precision Results Before Changing NSAIDs Safety Labeling
Feb-12-14 Washington, DC The US Food and Drug Administration (FDA) will wait until a large study currently underway is finished, before deciding whether labeling for non steroidal anti-inflammatory drugs (NSAIDs) including Celebrex and Naproxen, should contain warnings for increased risk of cardiac events. The FDA made the decision on the recommendation of...